Ventrus Biosciences (VTUS)

Add to Watchlists
Create an Alert
1.14 +0.03  +2.70% NASDAQ Apr 24, 5:00PM BATS Real time Currency in USD
View Full Chart
VTUS Price Chart
View All Performance Charts

VTUS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ventrus Biosciences is down 59.86% over the last year vs S&P 500 Total Return up 21.54%, AstraZeneca up 39.09%, and ntercept Pharmaceuticals up 674.2%.

Get Quote for

Portfolio Strategies Featuring VTUS

Did Ventrus Biosciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VTUS Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company. The Company is engaged in the late-stage clinical development of gastrointestinal products in areas of unmet need, anal fissures, and fecal incontinence.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VTUS 1.14 +0.03 +2.70% 26.67M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.